| Viatris Pharma GmbH - Femoston 1/10 mg, Tabletten | | 53128 | | 03 | | Femoston 1/10 mg | | Tabletten | | G03FB08 | | Dydrogesteron und Estrogen | | 30.03.2000 | | |
| | Composition | | I) Tablette weiss: estradiolum 1 mg ut estradiolum hemihydricum 1.03 mg, lactosum monohydricum 119.1 mg, hypromellosum, maydis amylum, silica colloidalis anhydrica, magnesii stearas, hypromellosum, macrogolum 400, E 171, pro compresso obducto.
II) Tablette grau: estradiolum 1 mg ut estradiolum hemihydricum 1.03 mg, dydrogesteronum 10 mg, lactosum monohydricum 110.2 mg, hypromellosum, maydis amylum, silica colloidalis anhydrica, magnesii stearas, poly(alcohol vinylicus), macrogolum 3350, talcum, E 171, E 172 (nigrum), pro compresso obducto. | | Packungsbestandteile | | I | | | Comprimés | | | | | Principe actif | Concentr. |
|---|
| Estradiol | 1 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Dydrogesterone | 10 mg | | Estradiol | 1 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| E 171 | | color. | | Hypromellosum | | | | Lactose Monohydrate | 119.1 mg | | | Macrogol | 400 | | | Magnesii Stearas | | | | Maydis Amylum | | | | Pro Compresso Obducto | | | | Silica Colloidalis Anhydrica | | |
| |
| II | | | Comprimés | | | | | Principe actif | Concentr. |
|---|
| Dydrogesterone | 10 mg | | Estradiol | 1 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Dydrogesterone | 10 mg | | Estradiol | 1 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| (Nigrum) | | | | E 171 | | color. | | E 172 | | color. | | Hypromellosum | | | | Lactose Monohydrate | 110.2 mg | | | Macrogol | 3350 | | | Magnesii Stearas | | | | Maydis Amylum | | | | Poly(Alcohol Vinylicus) | | | | Pro Compresso Obducto | | | | Silica Colloidalis Anhydrica | | | | Talcum | | |
| |
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 025 | 28 Comprimé(s) | 5.42 | 14.45 | B | LS | Oui |
|
|
